Healthcare Equities

The companies that provide, support or coordinate medical goods and services. This sector spans a broad range of activities – including the development and manufacture of medical equipment, pharmaceuticals and other treatments. Activities range from research to manufacturing, administration, insurance and facilities management. Our Healthcare research includes healthcare services, healthcare information technology (IT), medical devices, biotechnology, biopharmaceuticals and specialty pharmaceuticals.

Arron Aatkar, PhD | Healthcare | Comment | 1 day ago
Arron Aatkar, PhD | Healthcare | Comment | 1 day ago

IRLAB Therapeutics (IRLAB-A)

Latest price

SEK1.94

−0.06 (−2.90)
As at 26/11/2025
Market capitalisation
SEK165m
View equity

KALA BIO (KALA)

Latest price

USD0.91

0.27 (42.63)
As at 26/11/2025
Market capitalisation
USD7m

LTR Pharma (LTP)

Latest price

AUD0.48

0.02 (3.23)
As at 26/11/2025
Market capitalisation
AUD53m
View equity

Medigene (MDG1)

Latest price

EUR0.13

−0.05 (−27.57)
As at 26/11/2025
Market capitalisation
View equity

Mendus (IMMU)

Latest price

SEK5.30

0.32 (6.32)
As at 26/11/2025
Market capitalisation
SEK277m
View equity

Newron Pharmaceuticals (NWRN)

Latest price

CHF17.42

0.26 (1.52)
As at 26/11/2025
Market capitalisation
CHF311m
View equity

Nykode Therapeutics (NYKD)

Latest price

NOK2.18

0.05 (2.16)
As at 26/11/2025
Market capitalisation
NOK696m
View equity

Ocugen (OCGN)

Latest price

USD1.18

0.01 (0.85)
As at 26/11/2025
Market capitalisation
USD369m
View equity

Okyo Pharma (OKYO)

Latest price

USD1.97

−0.03 (−1.50)
As at 26/11/2025
Market capitalisation
USD75m
View equity

Oncopeptides (ONCO)

Latest price

SEK5.31

0.07 (1.34)
As at 26/11/2025
Market capitalisation
SEK1,373m
View equity

OpGen (OPGN)

Latest price

0.00 (0.00)
As at 26/11/2025
Market capitalisation
View equity
Laboratory Opgen

Update

Healthcare

OpGen — Cash concerns dampen active Q2

Laboratory Opgen

Flash note

Healthcare

OpGen — FIND collaboration advances to development

Flash note

Healthcare

OpGen — Feasibility milestone from FIND collaboration

Oryzon Genomics (ORY)

Latest price

EUR3.22

0.08 (2.38)
As at 26/11/2025
Market capitalisation
EUR258m
View equity

OSE Immunotherapeutics (OSE)

Latest price

EUR5.30

−0.02 (−0.28)
As at 26/11/2025
Market capitalisation
EUR119m
View equity

Percheron Therapeutics (PER)

Latest price

AUD0.01

0.00 (14.29)
As at 26/11/2025
Market capitalisation
AUD9m
View equity

Recce Pharmaceuticals (RCE)

Latest price

AUD0.45

0.02 (3.49)
As at 26/11/2025
Market capitalisation
AUD125m
View equity

Relief Therapeutics (RLF)

Latest price

CHF2.86

0.12 (4.39)
As at 26/11/2025
Market capitalisation
CHF41m